Literature DB >> 7814010

Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population.

H Bai1, K Saku, R Liu, M Imamura, K Arakawa.   

Abstract

Several studies have reported that a variant allele (S2) of the apolipoprotein (apo) A-I/C-III/A-IV complex is associated with hyperlipoproteinemia in some populations and that the frequency of this allele is two- to fivefold higher in patients with premature coronary heart disease (CHD) than in healthy controls. In the present study in a Japanese population, we were unable to confirm the association of the S2 allele with either coronary heart disease or elevated serum apo C-III levels, as has been previously reported in Caucasians. No genotype difference was observed among the severity of coronary heart disease, as determined by the number of involved vessels (one, two and three vessel disease), compared to controls. In addition, the frequency of the S2 allele among Japanese, in both CHD (0.328) and controls (0.369), was quite different from that in many other populations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814010     DOI: 10.1007/bf00225084

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

1.  Simultaneous determination of serum cholesterol in high- and low-density lipoproteins with use of heparin, Ca2+, and an anion-exchange resin.

Authors:  A Noma; K Nezu-Nakayama; M Kita; H Okabe
Journal:  Clin Chem       Date:  1978-09       Impact factor: 8.327

2.  Haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia. A study in a Japanese population.

Authors:  A Rees; J Stocks; H Paul; Y Ohuchi; D Galton
Journal:  Hum Genet       Date:  1986-02       Impact factor: 4.132

3.  DNA polymorphic patterns and haplotype arrangements of the apo A-1, apo C-III, apo A-IV gene cluster in different ethnic groups.

Authors:  H Paul; D Galton; J Stocks
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

4.  Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction.

Authors:  G A Ferns; J Stocks; C Ritchie; D J Galton
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

5.  A DNA polymorphism of the apolipoprotein C-III gene in extracoronary atherosclerosis.

Authors:  G O'Connor; J Stocks; J Lumley; D J Galton
Journal:  Clin Sci (Lond)       Date:  1988-03       Impact factor: 6.124

6.  [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors:  M Eggstein; F H Kreutz
Journal:  Klin Wochenschr       Date:  1966-03-01

7.  Isolation and characterization of cDNA clones corresponding to two different human apoC-III alleles.

Authors:  S K Karathanasis; V I Zannis; J L Breslow
Journal:  J Lipid Res       Date:  1985-04       Impact factor: 5.922

8.  DNA restriction fragment length polymorphisms as markers of familial coronary heart disease.

Authors:  W H Price; S W Morris; A H Kitchin; P R Wenham; P R Burgon; P M Donald
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

9.  Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII.

Authors:  C C Shoulders; P J Harry; L Lagrost; S E White; N F Shah; J D North; M Gilligan; P Gambert; M J Ball
Journal:  Atherosclerosis       Date:  1991-04       Impact factor: 5.162

10.  Automated immunoturbidimetric analysis of six plasma apolipoproteins: correlation with radial immunodiffusion assays.

Authors:  T Ikeda; Y Shibuya; U Senba; H Sugiuchi; S Araki; Y Uji; H Okabe
Journal:  J Clin Lab Anal       Date:  1991       Impact factor: 2.352

View more
  8 in total

1.  Study of apolipoproteinc3 Sstl polymorphism in healthy volunteers from Northern India.

Authors:  S Chhabra; D P Agarwal; S Vasisht; K Luthra; R Narang; S C Manchanda; L M Srivastava; N Das
Journal:  Indian J Clin Biochem       Date:  2003-07

2.  Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.

Authors:  S Chhabra; R Narang; R Lakshmy; S Vasisht; D P Agarwal; L M Srivastava; S C Manchanda; N Das
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

3.  Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis.

Authors:  Jing-Zhan Zhang; Xiang Xie; Yi-Tong Ma; Ying-Ying Zheng; Yi-Ning Yang; Xiao-Mei Li; Zhen-Yan Fu; Chuan-Fang Dai; Ming-Ming Zhang; Guo-Ting Yin; Fen Liu; Bang-Dang Chen; Min-Tao Gai
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

4.  Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.

Authors:  Yin Ruixing; Li Yiyang; Li Meng; Li Kela; Long Xingjiang; Zhang Lin; Liu Wanying; Wu Jinzhen; Yang Dezhai; Lin Weixiong
Journal:  Lipids Health Dis       Date:  2010-08-17       Impact factor: 3.876

5.  Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.

Authors:  Rui-Xing Yin; Yi-Yang Li; Chao-Qiang Lai
Journal:  Lipids Health Dis       Date:  2011-08-19       Impact factor: 3.876

6.  Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis.

Authors:  Yongyan Song; Liren Zhu; Mudwari Richa; Ping Li; Yang Yang; Suping Li
Journal:  Lipids Health Dis       Date:  2015-04-18       Impact factor: 3.876

7.  Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians.

Authors:  S Chhabra; R Narang; L R Krishnan; S Vasisht; D P Agarwal; L M Srivastava; S C Manchanda; N Das
Journal:  BMC Genet       Date:  2002-06-06       Impact factor: 2.797

8.  Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.

Authors:  Yanhua Wu; Yaqin Yu; Tiancheng Zhao; Shibin Wang; Yingli Fu; Yue Qi; Guang Yang; Wenwang Yao; Yingying Su; Yue Ma; Jieping Shi; Jing Jiang; Changgui Kou
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.